Literature DB >> 16922899

Comparison of major bile duct injuries following laparoscopic cholecystectomy and open cholecystectomy.

Lileswar Kaman1, Sudip Sanyal, Arunanshu Behera, Rajinder Singh, Rabindra N Katariya.   

Abstract

BACKGROUND: The mechanism and extent of major bile duct injuries following laparoscopic cholecystectomy differ from those of open cholecystectomy.
METHODS: To identify differences in the demographic profile, timing of injury detection, management strategies and outcome, we undertook a retrospective review and analysis of our experience with 55 major bile duct injuries following both laparoscopic and open cholecystectomies over a period of 9 years.
RESULTS: Thirty-one major bile duct injuries resulted from laparoscopic cholecystectomy (56%) and 24 of them were sustained after open cholecystectomy (44%). The median time of presentation was 7 days after laparoscopic cholecystectomy and 14 days following open cholecystectomy (P < 0.001). Twenty-eight (51%) patients had injuries recognized intraoperatively in both groups, of whom 18 patients underwent an attempt at primary repair before referral. All patients required subsequent surgical intervention. There were no differences in the clinical presentations between the two groups. However, serum alkaline phosphatase, alanine aminotransferase and aspartate aminotransferase levels were significantly higher following open cholecystectomy (P < 0.05). There was no significant difference in the level of injury between the two groups. All patients underwent surgical repair in the form of a Roux-en-Y hepaticojejunostomy (including two revision hepaticojejunostomies in each group). Surgical outcome did not differ between the groups; however, better results were seen with Bismuth grades 1 and 2 strictures compared with Bismuth grades 3 and 4 strictures for both groups (P < 0.002).
CONCLUSION: Major bile duct injuries following laparoscopic cholecystectomy present earlier and with lower levels of serum alkaline phosphatase, alanine aminotransferase and aspartate aminotransferase. There does not appear to be a significant difference between the Bismuth-Strasberg grading of the strictures and the type of surgery carried out.

Entities:  

Mesh:

Year:  2006        PMID: 16922899     DOI: 10.1111/j.1445-2197.2006.03868.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  7 in total

Review 1.  ERCP in the management of biliary complications after cholecystectomy.

Authors:  Swati Pawa; Firas H Al-Kawas
Journal:  Curr Gastroenterol Rep       Date:  2009-04

Review 2.  Iatrogenic bile duct injuries: etiology, diagnosis and management.

Authors:  Beata Jabłońska; Paweł Lampe
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

Review 3.  Long-Term Impact of Iatrogenic Bile Duct Injury.

Authors:  Anne Marthe Schreuder; Olivier R Busch; Marc G Besselink; Povilas Ignatavicius; Antanas Gulbinas; Giedrius Barauskas; Dirk J Gouma; Thomas M van Gulik
Journal:  Dig Surg       Date:  2019-01-17       Impact factor: 2.588

Review 4.  Recent classifications of the common bile duct injury.

Authors:  Kwangsik Chun
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-08-31

5.  A late unusual complication after an open cholecystectomy: Amputation neuroma of the CBD causing obstructive jaundice.

Authors:  Youssef A Sleiman; Ziad A Hassoun; Haydar A Nasser; Leila Abs; Mustafa Allouch
Journal:  Int J Surg Case Rep       Date:  2017-07-25

Review 6.  Diagnosis and Treatment of Biliary Fistulas in the Laparoscopic Era.

Authors:  M Crespi; G Montecamozzo; D Foschi
Journal:  Gastroenterol Res Pract       Date:  2015-12-24       Impact factor: 2.260

7.  Excision of a part of the bile duct as an iatrogenic injury typical for laparoscopic cholecystectomy - characteristics, treatment and long-term results, based on own material.

Authors:  Sergiusz Durowicz; Ireneusz Kozicki; Adam Ciesielski; Wiesław Tarnowski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-06-14       Impact factor: 1.195

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.